X1-Ffr
Payments companies reported to CMS as associated with X1-Ffr. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with X1-Ffr, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with X1-Ffr
These are the largest totals companies reported as associated with X1-Ffr. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ziad Ali | New York, NY | Internal Medicine | $5,000.00 |
| Haroon Faraz | Teaneck, NJ | Interventional Cardiology | $3,749.83 |
| Perwaiz Meraj | Manhasset, NY | Interventional Cardiology | $2,772.77 |
| Eric Cantey | Ann Arbor, MI | Cardiovascular Disease | $1,125.00 |
| Evan Shlofmitz | Roslyn, NY | Interventional Cardiology | $750.00 |
| Aglae Rene | Mount Kisco, NY | Interventional Cardiology | $692.55 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $87.28 |
Prescribed X1-Ffr?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.